I forløbet af behandlingen tilrådes passende bestemmelse af faktor VIII niveauer som rettesnor for dosis og den hyppighed med hvilken infusioner skal gentages.
In the case of major surgical interventions in particular, precise monitoring of the substitution therapy by means of coagulation analysis (plasma factor VIII activity) is indispensable.